Thursday, November 21, 2024 11/21/2024

Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age

Award Number: R01DK118072
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Aging is associated with functional decline of the hematopoietic system and clonal hematopoiesis (CH), a poorly understood process by which long-lived hematopoietic stem cells (HSCs) and their progeny with certain somatic mutations undergo positive selection. Individuals with CH have increased risk of developing blood cancer, cardiovascular disease, type 2 diabetes, and all-cause mortality. Thus, CH is a healthspan-limiting condition. Understanding how and why CH occurs with aging, and defining effective interventions to extend healthspan, have strong potential to reduce the frequency or severity of CH-associated diseases in aged individuals. Our laboratory has recently made formative discoveries that the aging bone marrow microenvironment and impaired HSC mitochondrial function cooperate to cause HSC aging. These discoveries have inspired us to define the components of aging that contribute to positive selection of CH- mutant HSCs. The major goal of this proposal is to determine processes by which hematopoietic-intrinsic and -extrinsic factors cause age-associated CH. Using a mouse model of a common CH mutation in DNMT3A, our preliminary data demonstrate that both hematopoietic-intrinsic and -extrinsic adaptive mechanisms facilitate selective advantage of Dnmt3a-mutant HSCs in the context of aging. We hypothesize that Dnmt3a-mutant HSCs are adapted to survive and self-renew in an aging microenvironment through enhanced mitochondrial metabolism, and that they promote premature senescence of the microenvironment to further their selective advantage. In Aim 1, we will identify the specific mitochondrial alterations in Dnmt3a-mutant HSCs that functionally increase their competitive advantage in an aging microenvironment. In Aim 2, we will determine the mechanisms by which Dnmt3a-mutant HSCs induce senescence of mesenchymal stromal cells in the BM microenvironment. In Aim 3, we will determine the extent to which targeting mesenchymal stromal cell senescence will reduce the functional competitive advantage of Dnmt3a-mutant HSCs and progression to hematologic pathology. Successful completion of this project will determine the mechanisms by which hematopoietic-intrinsic and -extrinsic processes confer a competitive advantage to Dnmt3a-mutant HSCs during aging. We expect that understanding these mechanisms will allow prioritization of targets for therapeutic intervention to limit CH-associated pathologies including myeloid malignancies, cardiovascular disease, and type 2 diabetes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $615,351 )
2024	2024	JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	6	2/23/2024	COMPETING CONTINUATION	$615,355
2024	2022	JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	1/24/2024	NON-COMPETING CONTINUATION	-$4
														Subtotal = $615,351

Issue Date FY: 2022 ( Subtotal = $478,279 )
2022	2022	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	6/29/2022	NON-COMPETING CONTINUATION	$478,279
														Subtotal = $478,279

Issue Date FY: 2021 ( Subtotal = $477,513 )
2021	2021	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	7/13/2021	NON-COMPETING CONTINUATION	$477,513
														Subtotal = $477,513

Issue Date FY: 2020 ( Subtotal = $477,513 )
2020	2020	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	6/15/2020	NON-COMPETING CONTINUATION	$477,513
														Subtotal = $477,513

Issue Date FY: 2019 ( Subtotal = $477,513 )
2019	2019	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	7/26/2019	NON-COMPETING CONTINUATION	$477,513
														Subtotal = $477,513

Issue Date FY: 2018 ( Subtotal = $473,290 )
2018	2018	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	7/23/2018	NEW	$473,290
														Subtotal = $473,290

Grand Total All Awards = $2,999,459

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age

Award Number: R01DK118072

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer